<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-04220345</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-19T07:31:22+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Targeted Strategies for Degradation of Key Transmembrane Proteins in Cancer</title>
            <author role="crp">
              <persName>
                <forename type="first">Vehary</forename>
                <surname>Sakanyan</surname>
              </persName>
              <email type="md5">60266f71e0ba992dd96623a63d1c2893</email>
              <email type="domain">univ-nantes.fr</email>
              <idno type="idhal" notation="numeric">773660</idno>
              <idno type="halauthorid" notation="string">902467-773660</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-0513-8434</idno>
              <idno type="IDREF">https://www.idref.fr/098415395</idno>
              <affiliation ref="#struct-534285"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Nina</forename>
                <surname>Iradyan</surname>
              </persName>
              <idno type="halauthorid">1675359-0</idno>
              <affiliation ref="#struct-424194"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Rodolphe</forename>
                <surname>Alves de Sousa</surname>
              </persName>
              <email type="md5">f94296eeb75ad9ccf2dff6f6c427a56c</email>
              <email type="domain">parisdescartes.fr</email>
              <idno type="idhal" notation="string">rodolphe-alves-de-sousa</idno>
              <idno type="idhal" notation="numeric">757528</idno>
              <idno type="halauthorid" notation="string">186704-757528</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-8815-3041</idno>
              <affiliation ref="#struct-301664"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>rodolphe</forename>
                <surname>ALVES DE SOUSA</surname>
              </persName>
              <email type="md5">f94296eeb75ad9ccf2dff6f6c427a56c</email>
              <email type="domain">parisdescartes.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2023-09-27 18:20:26</date>
              <date type="whenModified">2025-07-21 17:46:02</date>
              <date type="whenReleased">2023-09-27 18:20:26</date>
              <date type="whenProduced">2023-09</date>
              <ref type="externalLink" target="https://www.mdpi.com/2673-6284/12/3/57/pdf?version=1693996207"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="817357">
                <persName>
                  <forename>rodolphe</forename>
                  <surname>ALVES DE SOUSA</surname>
                </persName>
                <email type="md5">f94296eeb75ad9ccf2dff6f6c427a56c</email>
                <email type="domain">parisdescartes.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-04220345</idno>
            <idno type="halUri">https://cnrs.hal.science/hal-04220345</idno>
            <idno type="halBibtex">sakanyan:hal-04220345</idno>
            <idno type="halRefHtml">&lt;i&gt;BioTech&lt;/i&gt;, 2023, 12 (3), pp.57. &lt;a target="_blank" href="https://dx.doi.org/10.3390/biotech12030057"&gt;&amp;#x27E8;10.3390/biotech12030057&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">BioTech, 2023, 12 (3), pp.57. &amp;#x27E8;10.3390/biotech12030057&amp;#x27E9;</idno>
            <availability status="restricted"/>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="UNIV-PARIS">Université Paris Cité</idno>
            <idno type="stamp" n="UNIVERSITE-PARIS" corresp="UNIV-PARIS">Université Paris Cité</idno>
            <idno type="stamp" n="NANTES-UNIVERSITE">Nantes Université</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Targeted Strategies for Degradation of Key Transmembrane Proteins in Cancer</title>
                <author role="crp">
                  <persName>
                    <forename type="first">Vehary</forename>
                    <surname>Sakanyan</surname>
                  </persName>
                  <email type="md5">60266f71e0ba992dd96623a63d1c2893</email>
                  <email type="domain">univ-nantes.fr</email>
                  <idno type="idhal" notation="numeric">773660</idno>
                  <idno type="halauthorid" notation="string">902467-773660</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-0513-8434</idno>
                  <idno type="IDREF">https://www.idref.fr/098415395</idno>
                  <affiliation ref="#struct-534285"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Nina</forename>
                    <surname>Iradyan</surname>
                  </persName>
                  <idno type="halauthorid">1675359-0</idno>
                  <affiliation ref="#struct-424194"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Rodolphe</forename>
                    <surname>Alves de Sousa</surname>
                  </persName>
                  <email type="md5">f94296eeb75ad9ccf2dff6f6c427a56c</email>
                  <email type="domain">parisdescartes.fr</email>
                  <idno type="idhal" notation="string">rodolphe-alves-de-sousa</idno>
                  <idno type="idhal" notation="numeric">757528</idno>
                  <idno type="halauthorid" notation="string">186704-757528</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-8815-3041</idno>
                  <affiliation ref="#struct-301664"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">167386</idno>
                <idno type="issn">2673-6284</idno>
                <title level="j">BioTech</title>
                <imprint>
                  <publisher>MDPI</publisher>
                  <biblScope unit="volume">12</biblScope>
                  <biblScope unit="issue">3</biblScope>
                  <biblScope unit="pp">57</biblScope>
                  <date type="datePub">2023-09</date>
                </imprint>
              </monogr>
              <idno type="doi">10.3390/biotech12030057</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <classCode scheme="halDomain" n="sdv">Life Sciences [q-bio]</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Targeted protein degradation is an attractive technology for cancer treatment due to its ability to overcome the unpredictability of the small molecule inhibitors that cause resistance mutations. In recent years, various targeted protein degradation strategies have been developed based on the ubiquitin–proteasome system in the cytoplasm or the autophagy–lysosomal system during endocytosis. In this review, we describe and compare technologies for the targeted inhibition and targeted degradation of the epidermal growth factor receptor (EGFR), one of the major proteins responsible for the onset and progression of many types of cancer. In addition, we develop an alternative strategy, called alloAUTO, based on the binding of new heterocyclic compounds to an allosteric site located in close proximity to the EGFR catalytic site. These compounds cause the targeted degradation of the transmembrane receptor, simultaneously activating both systems of protein degradation in cells. Damage to the EGFR signaling pathways promotes the inactivation of Bim sensor protein phosphorylation, which leads to the disintegration of the cytoskeleton, followed by the detachment of cancer cells from the extracellular matrix, and, ultimately, to cancer cell death. This hallmark of targeted cancer cell death suggests an advantage over other targeted protein degradation strategies, namely, the fewer cancer cells that survive mean fewer chemotherapy-resistant mutants appear.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="regrouplaboratory" xml:id="struct-534285" status="OLD">
          <orgName>Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques</orgName>
          <orgName type="acronym">UFR SPB</orgName>
          <date type="end">2021-12-31</date>
          <desc>
            <address>
              <addrLine>9 rue Bias - BP 61112 - 44035 Nantes Cedex1</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.pharmacie.univ-nantes.fr/</ref>
          </desc>
          <listRelation>
            <relation name="93263" active="#struct-93263" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-424194" status="VALID">
          <orgName>National Academy of Sciences of the Republic of Armenia [Yerevan]</orgName>
          <orgName type="acronym">NAS RA</orgName>
          <desc>
            <address>
              <country key="AM"/>
            </address>
            <ref type="url">http://www.sci.am/index.php?langid=2</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-301664" status="OLD">
          <idno type="IdRef">026404788</idno>
          <idno type="ISNI">0000 0001 2188 0914 </idno>
          <idno type="ROR">https://ror.org/0220k9r37</idno>
          <orgName>Université Paris Descartes - Paris 5</orgName>
          <orgName type="acronym">UPD5</orgName>
          <date type="start">1971-01-01</date>
          <date type="end">2019-12-31</date>
          <desc>
            <address>
              <addrLine>12, rue de l'École de Médecine - 75270 Paris cedex 06</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.parisdescartes.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-93263" status="OLD">
          <idno type="IdRef">026403447</idno>
          <idno type="ROR">https://ror.org/03gnr7b55</idno>
          <orgName>Université de Nantes</orgName>
          <orgName type="acronym">UN</orgName>
          <date type="end">2021-12-31</date>
          <desc>
            <address>
              <addrLine>1, quai de Tourville - BP 13522 - 44035 Nantes cedex 1</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-nantes.fr/</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>